Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Verona Pharma PLC
Net Income Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Net Income
-$153.7m
CAGR 3-Years
-60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Net Income
ÂŁ4.3B
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Net Income
$7.7B
CAGR 3-Years
21%
CAGR 5-Years
30%
CAGR 10-Years
13%
Indivior PLC
LSE:INDV
Net Income
-$189m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Net Income
$367m
CAGR 3-Years
-15%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Net Income
ÂŁ6.3m
CAGR 3-Years
-51%
CAGR 5-Years
-29%
CAGR 10-Years
-10%

See Also

What is Verona Pharma PLC's Net Income?
Net Income
-153.7m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Net Income amounts to -153.7m USD.

What is Verona Pharma PLC's Net Income growth rate?
Net Income CAGR 3Y
-60%

Over the last year, the Net Income growth was -203%. The average annual Net Income growth rates for Verona Pharma PLC have been -60% over the past three years .

Back to Top